1 Dalan R, "The ACE-2 in COVID-19 : foe or friend?" 52 : 257-263, 2020
2 Yan R, "Structural basis for the recognition of the SARS-CoV-2 by full length human ACE-2" 367 : 1444-1448, 2020
3 European Centre for Disease Prevention and Control (ECDC)., "Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children – 15 May 2020" ECDC
4 Bunyavanich S, "Nasal gene expression of angiotensinconverting enzyme 2 in children and adults" 323 : 2427-2429, 2020
5 World Health Organization (WHO), "Multisystem inflammatory syndrome in children and adolescents with COVID-19. Scientific brief" WHO
6 U.S. Centers for Disease Control and Prevention (CDC), "Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19)" CDC
7 Garg M, "Letter : intestinal inflammation, COVID-19and gastrointestinal ACE2-exploring RAS inhibitors" 52 : 569-570, 2020
8 Riphagen S, "Hyperinflammatory shock in children during COVID-19 pandemic" 395 : 1607-1608, 2020
9 Zimmermann P, "Coronavirus infections in children including COVID-19" 39 : 355-368, 2020
10 Guo J, "Coronavirus Disease 2019(COVID-19)and cardiovascular disease : a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2infection" 9 : e016219-, 2020
1 Dalan R, "The ACE-2 in COVID-19 : foe or friend?" 52 : 257-263, 2020
2 Yan R, "Structural basis for the recognition of the SARS-CoV-2 by full length human ACE-2" 367 : 1444-1448, 2020
3 European Centre for Disease Prevention and Control (ECDC)., "Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children – 15 May 2020" ECDC
4 Bunyavanich S, "Nasal gene expression of angiotensinconverting enzyme 2 in children and adults" 323 : 2427-2429, 2020
5 World Health Organization (WHO), "Multisystem inflammatory syndrome in children and adolescents with COVID-19. Scientific brief" WHO
6 U.S. Centers for Disease Control and Prevention (CDC), "Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19)" CDC
7 Garg M, "Letter : intestinal inflammation, COVID-19and gastrointestinal ACE2-exploring RAS inhibitors" 52 : 569-570, 2020
8 Riphagen S, "Hyperinflammatory shock in children during COVID-19 pandemic" 395 : 1607-1608, 2020
9 Zimmermann P, "Coronavirus infections in children including COVID-19" 39 : 355-368, 2020
10 Guo J, "Coronavirus Disease 2019(COVID-19)and cardiovascular disease : a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2infection" 9 : e016219-, 2020
11 Kwak Ji Hee, "Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease 2019" 대한소아청소년과학회 64 (64): 68-75, 2021
12 South AM, "COVID-19, ACE2, and the cardiovascular consequences" 318 : H1084-, 2020
13 Verdoni L, "An outbreak of severe Kawasaki-like disease at the Italian epicenter of the SARS-CoV-2 epidemic : an observational cohort study" 395 : 1771-1778, 2020